HBM Healthcare Investments AG

HBM Healthcare Investments publishes interim report for the quarter ended 30 June 2023 with key figures for the first three months of the 2023/2024 financial year

Cathay Biotech raises capital and enters into major strategic collaboration with China Merchants Group

Publication of Annual Report 2022/2023 and Invitation to the Ordinary Shareholders’ Meeting

HBM Healthcare Investments year-end results 2022/2023

HBM Healthcare Investments publishes net asset value per share of CHF 254.80 as at 31 March 2023

HBM Healthcare Investments announces the return of Dr Andreas Wicki; new investment of USD 12 million in ArriVent Biopharma